Home
Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc. Market Share Analysis for July 2026

WALTHAM, Mass.–(BUSINESS WIRE)– Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for autoimmune and rare diseases, today announced the pricing of its upsized underwritten public offering of $225.0 million aggregate principal amount of its 1.75% convertible senior notes due 2032 (the “Convertible Notes” and such offering,Read More

Health > Biotechnology and Pharmaceuticals

Domainviridiantherapeutics.com

Year Founded2006

Employees51 - 200

Annual Revenue$50M - $75M

Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc. (including company regionals)

viridiantherapeutics.com

See more website traffic and engagement information

Viridian Therapeutics, Inc. Revenue up to July 2026 is 50M - 75M

revenue generated by Viridian Therapeutics, Inc. top domains

Viridian Therapeutics, Inc. top domains revenue over 3 years

Revenue for Viridian Therapeutics, Inc. top domains

viridiantherapeutics.com50M - 75M

See more with Sales Intelligence

Total visits to Viridian Therapeutics, Inc.'s top domains

Understand Viridian Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

viridiantherapeutics.com15.4K

See more with Sales Intelligence

Avg. visit duration in Viridian Therapeutics, Inc.'s top domains

Analyze Viridian Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

viridiantherapeutics.com00:00:32

See more with Sales Intelligence

Avg. pageviews on Viridian Therapeutics, Inc.'s top domains

See how Viridian Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

viridiantherapeutics.com1.66

See more with Sales Intelligence

Viridian Therapeutics, Inc. top competitors by domain

Top similar sites in July 2026, ranked by their affinity

discmedicine.comCompany NameDisc Medicine, Inc.Employees51 - 200HQUnited States, Massachusetts, WatertownAnnual revenue--Total visits5.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Viridian Therapeutics, Inc.

These are the website technologies, by industry, used by Viridian Therapeutics, Inc. top domains

Widget (5)

Twemoji

Marketing (3)

Google Marketing Platform

Advertising (2)

DoubleClick

Conversion & Analytics (2)

Google Analytics

More Technologies

7

See all

News & Signals from Viridian Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsViridian Therapeutics, Inc. had revenue of $280K on Aug 11th '26.* Quarterly results fell slightly short of expectations: Viridian reported a loss of $1.05 per share, missing the $1.03 consensus estimate, while revenue of $0.28 million exceeded expectations.

NewsViridian Therapeutics Inc. launched ViridianCares on Jun 29th '26.Viridian has also launched ViridianCares, a patient support program offering coverage assistance, benefit verification and financial assistance for eligible patients.

NewsViridian Therapeutics Inc. identified as competitor of Amgen Foundation, Inc. on Jun 29th '26.For Viridian, Lumvoa is the company's first commercial product and positions it as a direct competitor to Amgen in a rare disease indication with an established, high-value treatment precedent.